- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03341975
Enhanced SexHealth Intervention to Improve Adolescent Outcomes
February 9, 2021 updated by: Children's Mercy Hospital Kansas City
Enhanced SexHealth Intervention to Improve Adolescent Outcomes: A Clinical Trial
This is an adaptive trial with an initial Formative Revision Process followed by a Randomized Controlled Trial (RCT).
Up to 500 adolescents will be consented into this study to achieve 6 completed subjects for the formative process and 86 completed subjects for the RCT.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
In a randomized controlled trial at a pediatric emergency department, sexually active adolescents will receive the control (i.e., printed materials) or intervention (i.e., motivationally-guided facilitation) arm delivered by a health educator.
The tablet-based, interactive intervention includes motivational techniques to promote risk reduction, condom skills training, and tailored service recommendations.
The primary outcome is uptake of ≥1 service at the index visit (i.e., counseling, condoms, emergency contraception for immediate or future use, pregnancy/sexually transmitted infection (STI)/HIV testing, STI treatment, and clinic referral).
We assess feasibility (i.e., intervention completion, recommendations discussed, and satisfaction).
Participants report sexual risk and care-seeking behaviors at 2, 4, and 6 months.
We compare uptake between arms using Fisher exact tests.
Study Type
Interventional
Enrollment (Actual)
91
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Kansas City, Missouri, United States, 64108
- Children's Mercy Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 19 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 14-19 years old
- Reside within 30 minutes travel time
- Report previous sexual activity
Exclusion Criteria:
- Subjects who are unable to provide consent (i.e., determined to be too ill by the ED team, have cognitive impairment due to chronic condition or acute medical concern)
- Subjects in police custody
- Subjects seeking care due to sexual assault or psychiatric emergency
- Subjects who do not speak English
- Subjects who are patients under the clinical care of a study investigator working in the ED
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
They will receive the same pamphlet as controls and the enhanced ED SexHealth intervention with the educator.
Based on behaviors, CDS system recommendations (generated from screening survey responses only for intervention participants), and discussions, participants may be offered testing (for pregnancy, gonorrhea/chlamydia, and /or HIV), hormonal birth control, condoms, emergency contraception (for immediate or future use), treatment for previously diagnosed (yet untreated) infection with gonorrhea/chlamydia, and a scheduled appointment at Adolescent Clinic (for ongoing care, including repeat STI/HIV testing if needed).
All services will be provided at point of care, costs will be covered by the study.
|
To enhance and test our ED SexHealth intervention that provides risk reduction counseling and point-of-care services as well as connections to sustainable, non-episodic sources of care.
|
No Intervention: Control
They will receive a printed health pamphlet and a list of local resources with the phone number for Adolescent Clinic.
Participants will then be referred back to their ED provider, who will provide their standard care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Uptake of 1 or More Health Services
Time Frame: Index visit
|
Any 1 or more of the following services: Testing for pregnancy, gonorrhea/chlamydia, and/or HIV, hormonal birth control, condoms, emergency contraception (for immediate or future use), treatment for previously diagnosed (yet untreated) infection with gonorrhea/chlamydia, appointment for clinic referral.
|
Index visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Melissa Miller, MD, Children's Mercy Hospital Kansas City
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2017
Primary Completion (Actual)
April 30, 2020
Study Completion (Actual)
May 1, 2020
Study Registration Dates
First Submitted
November 6, 2017
First Submitted That Met QC Criteria
November 9, 2017
First Posted (Actual)
November 14, 2017
Study Record Updates
Last Update Posted (Actual)
February 25, 2021
Last Update Submitted That Met QC Criteria
February 9, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17010079
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sexually Transmitted Diseases
-
Columbia UniversityNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingSTI | Sexually Transmitted Disease (STD) | Sexually Transmitted Infection (STI)United States
-
National Institute of Allergy and Infectious Diseases...Terminated
-
Boston Medical CenterCompletedSexually Transmitted InfectionUnited States
-
University of ChicagoCompletedSexually Transmitted InfectionUnited States
-
University of California, San FranciscoNational Institute of Mental Health (NIMH); MRC/UVRI and LSHTM Uganda Research... and other collaboratorsCompletedSexually Transmitted InfectionUganda
-
Assistance Publique Hopitaux De MarseilleCompletedSexually Transmitted InfectionFrance
-
Boston Medical CenterCompletedSexually Transmitted InfectionUnited States
-
University of Illinois at ChicagoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedHiv | Sexually Transmitted InfectionSouth Africa
-
Chinese University of Hong KongRecruitingGonorrhea | Sexually Transmitted InfectionHong Kong
-
Sagami Rubber Industries Co., Ltd.Essential Access HealthCompletedContraception | Prevention of Sexually Transmitted InfectionsUnited States
Clinical Trials on SexHealth
-
Children's Mercy Hospital Kansas CityUniversity of Kansas Medical Center; Swope Health Services, Kansas City MissouriCompletedContraception | Contraceptive UsageUnited States
-
Children's Mercy Hospital Kansas CityCompletedPregnancy | Pregnancy Related | Contraception | Contraception Behavior | Contraceptive UsageUnited States